Transfusional Hemosiderosis
5 clinical trials · Condition
◉ Watch Transfusional Hemosiderosis
| Record | Firm | Date |
|---|---|---|
| Treatment of Iron Overload Requiring Chelation Therapy (NCT01927913) | Shire | 2014-11-20 |
| Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox (NCT01394029) | Novartis Pharmaceuticals | 2011-07-01 |
| Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food (NCT00845871) | Novartis Pharmaceuticals | 2009-05-01 |
| Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload (NCT00600938) | Novartis Pharmaceuticals | 2007-11-01 |
| Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis (NCT00631163) | Novartis Pharmaceuticals | 2007-10-01 |
Track Transfusional Hemosiderosis automatically
Every clearance here is in the API, with alerts when new ones post.